We also reported that N-cadherin is associated with tumor aggressiveness in esophageal carcinoma [30], and others demonstrated the value of N-cadherin as a marker of invasive, malignant tumors [29,31], supporting our finding that N-cadherin expression in PB may be a predictive biomarker of NM. Here, CDH2 is linked to cancer.